PRLog (Press Release) –
Oct 09, 2007 – MONROVIA, CA – GTCbio is announcing its premier research and networking forum – the 3rd Modern Drug Discovery and Development Summit taking place on November 28-30, 2007 in San Francisco, CA – covering novel drug discovery trends and developments all across the industry.
Today, GTCbio confirmed the participation of the four plenary keynote presenters who will open up this year’s Modern Drug Discovery & Development Summit. Nobel Laureate Ferid Murad, Director at UT Houston, Neil Bodick, COO – Chorus at Eli Lilly, Mahdi Fawzi, EVP, Pre-Clinical Research at Wyeth Research and Keith James, SVP and Site Head at Pfizer La Jolla will be the first of over 150 speakers to present at this event.
The goal of the summit is to capture a landscape and in-depth analysis of emerging advancements in the biopharma industry. With 6 concurrent tracks on Biological Therapeutics, Drug Delivery Technology, Translational Medicine, Drug Design and Lead Optimization, Emerging Targets, and Pharmaco – Kinetics, Dynamics, Genomics and Genetics, as well as 6 study sessions (Preparing INDs, Signaling Pathways, Salvaging Compounds from Drug Attrition, Stem Cells, Systems Bio, Toxicology and Safety) and 3 pre-conference workshops (Biotech & Pharma Partnering, Bioanalytics Methods, Clinical Research) the summit will provide an outlook into the future of treatments and therapies from top experts in the industry.
For more information on GTCbio’s 3rd Modern Drug Discovery and Development Summit, visit www.gtcbio.com.
